Shilpa Medicare

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE790G01031
  • NSEID: SHILPAMED
  • BSEID: 530549
INR
531.35
-14.85 (-2.72%)
BSENSE

Jun 15, 03:09 PM

BSE+NSE Vol: 7.98 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
436.99
410.28
369.97
321.46
330.82
319.30
343.80
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
436.99
410.28
369.97
321.46
330.82
319.30
343.80
Raw Material Cost
127.57
100.75
127.64
115.04
85.51
90.05
98.55
Purchase of Finished goods
6.98
7.14
7.36
4.16
6.29
6.64
5.92
(Increase) / Decrease In Stocks
7.44
25.43
-29.50
-39.59
12.69
-5.68
17.51
Employee Cost
86.56
83.46
83.05
81.81
70.93
73.49
76.16
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
-0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
88.73
78.65
73.14
68.40
76.19
74.16
59.66
Total Expenditure (Excl Depreciation)
317.28
295.43
261.69
229.82
251.61
238.65
257.80
Operating Profit (PBDIT) excl Other Income
119.71
114.85
108.28
91.64
79.21
80.65
86.00
Other Income
1.67
0.26
1.75
6.38
7.63
1.18
4.99
Operating Profit (PBDIT)
121.38
115.11
110.03
98.02
86.84
81.83
90.99
Interest
13.66
10.68
15.67
18.78
14.49
11.75
25.55
Exceptional Items
25.02
-12.86
0.00
0.00
-30.59
0.00
0.00
Gross Profit (PBDT)
132.74
91.57
94.36
79.24
41.76
70.08
65.44
Depreciation
30.62
30.36
29.82
28.92
28.79
28.81
28.28
Profit Before Tax
120.44
60.85
64.43
49.58
15.27
41.61
36.77
Tax
12.65
16.27
20.36
2.69
0.76
9.83
18.83
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
89.47
44.94
44.18
47.62
12.21
31.44
18.33
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
89.47
44.94
44.18
47.62
12.21
31.44
18.33
Share in Profit of Associates
18.32
-0.36
-0.11
-0.73
2.30
0.34
-0.39
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.01
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
107.79
44.58
44.07
46.89
14.51
31.78
17.94
Equity Capital
19.56
19.56
9.78
9.78
19.56
9.78
9.78
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
5.51
2.28
2.25
2.4
0.37
1.62
0.92
Diluted Earnings per share
5.51
2.28
2.75
2.4
0.37
1.62
0.92
Operating Profit Margin (Excl OI)
27.39%
27.99%
29.27%
28.51%
23.94%
25.26%
25.01%
Gross Profit Margin
30.38%
22.32%
25.5%
24.65%
12.62%
21.95%
19.03%
PAT Margin
24.67%
10.87%
11.91%
14.59%
4.39%
9.95%
5.22%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 6.51% vs 10.90% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 141.79% vs 1.16% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 4.23% vs 6.07% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 27.90% vs -31.84% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of Shilpa Medicare With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
436.99
0
436.99
Other Operating Income
0.00
0.00
0.00
Total Operating income
436.99
0
436.99
Raw Material Cost
127.57
0
127.57
Purchase of Finished goods
6.98
0
6.98
(Increase) / Decrease In Stocks
7.44
0
7.44
Employee Cost
86.56
0
86.56
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
88.73
0.00
88.73
Total Expenditure (Excl Depreciation)
317.28
0
317.28
Operating Profit (PBDIT) excl Other Income
119.71
0.00
119.71
Other Income
1.67
0
1.67
Operating Profit (PBDIT)
121.38
0
121.38
Interest
13.66
0
13.66
Exceptional Items
25.02
0
25.02
Gross Profit (PBDT)
132.74
0
132.74
Depreciation
30.62
0
30.62
Profit Before Tax
120.44
0
120.44
Tax
12.65
0
12.65
Provisions and contingencies
0.00
0
0.00
Profit After Tax
89.47
0
89.47
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
89.47
0
89.47
Share in Profit of Associates
18.32
0
18.32
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
107.79
0
107.79
Equity Capital
19.56
0
19.56
Face Value
1.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
5.51
0
5.51
Diluted Earnings per share
5.51
0
5.51
Operating Profit Margin (Excl OI)
27.39%
0%
0.00
27.39%
Gross Profit Margin
30.38%
0%
0.00
30.38%
PAT Margin
24.67%
0%
0.00
24.67%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 436.99 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 6.51% vs 10.90% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 32.09% vs 13.41% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 107.79 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 141.79% vs 1.16% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 642.87% vs -40.78% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 119.71 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 4.23% vs 6.07% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 51.13% vs 13.06% in Mar 2025

Quarterly - Interest
Interest 13.66 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 27.90% vs -31.84% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -5.73% vs -40.12% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.39%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025